Santini recently retired from a 27-year career at Eli Lilly, where he was most recently senior vice president of corporate strategy and business development.
A spokesperson for Allena said of his new role: “The Allena founding team has successfully worked with Mr. Santini in the past and his strategic insights and proven expertise will be of significant value to the company as it accelerates the development of its non-systemic protein therapeutics.”
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...
Who's in, who's out: all the latest changes in senior pharmaceutical appointments.
Plus senior hires at Merck Serono, Astellas, the European Medicines Agency, and more.
Our People on the Move column tracks pharma's movers and shakers.